These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


316 related items for PubMed ID: 11547740

  • 1. Infection with GB virus C and reduced mortality among HIV-infected patients.
    Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP.
    N Engl J Med; 2001 Sep 06; 345(10):715-24. PubMed ID: 11547740
    [Abstract] [Full Text] [Related]

  • 2. Effect of coinfection with GB virus C on survival among patients with HIV infection.
    Xiang J, Wünschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT.
    N Engl J Med; 2001 Sep 06; 345(10):707-14. PubMed ID: 11547739
    [Abstract] [Full Text] [Related]

  • 3. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M.
    J Biol Regul Homeost Agents; 2003 Sep 06; 17(2):191-4. PubMed ID: 14518722
    [Abstract] [Full Text] [Related]

  • 4. Persistent GB virus C infection and survival in HIV-infected men.
    Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, Liu C, Phair J, Margolick JB, Zdunek D, Hess G, Stapleton JT.
    N Engl J Med; 2004 Mar 04; 350(10):981-90. PubMed ID: 14999110
    [Abstract] [Full Text] [Related]

  • 5. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB, Remis RS, Raboud J, Millson M, Tappero J, Kaul R, Kulkarni P, McConnell MS, Mock PA, Culnane M, McNicholl J, Roongpisuthipong A, Chotpitayasunondh T, Shaffer N, Butera S.
    J Infect Dis; 2008 May 15; 197(10):1369-77. PubMed ID: 18419578
    [Abstract] [Full Text] [Related]

  • 6. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons.
    Lefrère JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M, Mariotti M.
    J Infect Dis; 1999 Apr 15; 179(4):783-9. PubMed ID: 10068572
    [Abstract] [Full Text] [Related]

  • 7. GB virus C genotype determination in GB virus-C/HIV co-infected individuals.
    Muerhoff AS, Tillmann HL, Manns MP, Dawson GJ, Desai SM.
    J Med Virol; 2003 May 15; 70(1):141-9. PubMed ID: 12629656
    [Abstract] [Full Text] [Related]

  • 8. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.
    Li C, Collini P, Danso K, Owusu-Ofori S, Dompreh A, Candotti D, Opare-Sem O, Allain JP.
    AIDS; 2006 Feb 14; 20(3):379-86. PubMed ID: 16439871
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH, Hung CC, Wu RJ, Wang JT, Chen PJ, Chang SC, Kao JH.
    Clin Infect Dis; 2007 Feb 15; 44(4):584-90. PubMed ID: 17243064
    [Abstract] [Full Text] [Related]

  • 10. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
    Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, Sherman KE, Zdunek D, Hess G, Chung RT, AIDS Clinical Trial Group A5071 Study Team.
    J Infect Dis; 2006 Aug 15; 194(4):410-9. PubMed ID: 16845623
    [Abstract] [Full Text] [Related]

  • 11. No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2.
    Kaye S, Howard M, Alabi A, Hansmann A, Whittle H, Schim van der Loeff M.
    Clin Infect Dis; 2005 Mar 15; 40(6):876-8. PubMed ID: 15736023
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy.
    Alcalde R, Nishiya A, Casseb J, Inocêncio L, Fonseca LA, Duarte AJ.
    Virus Res; 2010 Aug 15; 151(2):148-52. PubMed ID: 20420864
    [Abstract] [Full Text] [Related]

  • 13. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study.
    Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, Coutinho RA, Schuitemaker H.
    J Infect Dis; 2005 Mar 01; 191(5):678-85. PubMed ID: 15688280
    [Abstract] [Full Text] [Related]

  • 14. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT.
    HIV Med; 2006 Jan 01; 7(1):25-31. PubMed ID: 16313289
    [Abstract] [Full Text] [Related]

  • 15. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, Morsica G, Pizzaferri P, Ladisa N, Sighinolfi L, Chiodera A, Solmone M, Lalle E, Ippolito G, Monforte Ad, HepaICoNA Study Group, ICoNA Study Group.
    Antivir Ther; 2005 Jan 01; 10(1):109-17. PubMed ID: 15751768
    [Abstract] [Full Text] [Related]

  • 16. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
    Berzsenyi MD, Bowden DS, Roberts SK, Revill PA.
    J Gastroenterol Hepatol; 2009 Aug 01; 24(8):1407-10. PubMed ID: 19702909
    [Abstract] [Full Text] [Related]

  • 17. Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.
    Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT.
    HIV Med; 2006 Apr 01; 7(3):173-80. PubMed ID: 16494631
    [Abstract] [Full Text] [Related]

  • 18. [GB virus C: lack of association with transaminases levels, CD4 and HIV viral load in aids patients].
    López Calvo S, Vela A, Castro A, Cid A, Aguilera A, Vega P, Hermida M, Regueiro BJ, Pedreira JD.
    An Med Interna; 2003 Apr 01; 20(4):175-8. PubMed ID: 12768829
    [Abstract] [Full Text] [Related]

  • 19. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 20. GBV-C viremia and clinical events in advanced HIV infection.
    Sahni H, Kirkwood K, Kyriakides TC, Stapleton J, Brown ST, Holodniy M, OPTIMA Study Team.
    J Med Virol; 2014 Mar 15; 86(3):426-32. PubMed ID: 24249700
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.